Mostrar el registro sencillo del ítem
| dc.contributor.author | Carmona-Bayonas, Alberto | |
| dc.contributor.author | Marino-Mendez, Axel | |
| dc.contributor.author | Vicente-Conesa, María-Ángeles | |
| dc.contributor.author | Jiménez-Fonseca, Paula | |
| dc.contributor.author | de-Toro-Carmena, María | |
| dc.contributor.author | Guillen-Ponce, Carmen | |
| dc.contributor.author | Lamarca, Angela | |
| dc.contributor.author | Benavente, Mónica | |
| dc.contributor.author | Gallego, Javier | |
| dc.contributor.author | Cerda-Serda, Paula | |
| dc.contributor.author | Hernández-San-Gil, Raquel | |
| dc.contributor.author | Vega-Cano, Kreina-Sharela | |
| dc.contributor.author | López, Ana | |
| dc.contributor.author | Soriano-Tabares-de-Navas, María-Luisa | |
| dc.contributor.author | Peiro, Inmaculada | |
| dc.contributor.author | Parra-Paladines, Wagner | |
| dc.contributor.author | Zwisler-Contreras, Patricia | |
| dc.contributor.author | Brozos-Vázquez, Elena | |
| dc.contributor.author | Cabezon-Gutiérrez, Luis | |
| dc.contributor.author | Munoz-Martin, Andrés | |
| dc.contributor.author | Pacheco-Barcia, Vilma | |
| dc.date.accessioned | 2026-11-11T09:07:19Z | |
| dc.date.available | 2026-11-11T09:07:19Z | |
| dc.date.issued | 2026-11 | |
| dc.identifier.citation | Carmona-Bayonas A, Mariño Méndez A, Vicente-Conesa MÁ, Jimenez-Fonseca P, De Toro Carmena M, Guillen-Ponce C, et al. Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. Pancreatology. noviembre de 2026;26(7):995-1004. doi:10.1016/j.pan.2026.08.008 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/29203 | |
| dc.description.abstract | BACKGROUND: Systemic inflammation is a key driver of progression in pancreatic ductal adenocarcinoma (PDAC). We aimed to externally validate the Systemic Inflammation Response Index (SIRI) and define its non-linear prognostic value in a large multicenter cohort. METHODS: We analyzed 672 patients with metastatic PDAC receiving first-line chemotherapy across 30 centers. SIRI was assessed using a validated cut-off (>2.3) and as a log-transformed continuous variable in multivariable Weibull accelerated failure-time models with restricted cubic splines. RESULTS: Patients with low SIRI (?2.3) had longer median OS (14.0 vs 9.2 months; p < 0.001) and PFS (5.9 vs 3.9 months; p < 0.001) than those with high SIRI. High SIRI was associated with a lower objective response rate (25% vs 37%; p < 0.001). In multivariable analyses, higher SIRI independently predicted inferior OS and PFS (75th vs 25th percentile: HR 1.14 [95% CI 1.05-1.25], HR 1.11 [95% CI 1.03-1.21]) and poorer tumor response (OR 0.78; 95% CI 0.62-1.00). Higher SIRI correlated with greater hepatic tumor burden and cachexia. CONCLUSIONS: SIRI is a robust, independent prognostic marker in metastatic PDAC. Higher values identify a phenotype with inferior survival and poorer tumor response. An open-access web calculator is provided to illustrate and explore the nonlinear, continuous prognostic gradient of SIRI and its impact on outcome. | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER BV | |
| dc.rights | Atribución/Reconocimiento 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by/4.0/deed.es | * |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Pancreatic Neoplasms/drug therapy/pathology | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Middle Aged | |
| dc.subject.mesh | Carcinoma, Pancreatic Ductal/drug therapy/pathology | |
| dc.subject.mesh | Inflammation/pathology | |
| dc.subject.mesh | Prognosis | |
| dc.subject.mesh | Treatment Outcome | |
| dc.subject.mesh | Antineoplastic Agents/therapeutic use | |
| dc.subject.mesh | Neoplasm Metastasis | |
| dc.subject.mesh | Cohort Studies | |
| dc.title | Systemic inflammation response index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group. | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 42601286 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S1424390326008793 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1016/j.pan.2026.08.008 | |
| dc.journal.title | Pancreatology : Official Journal of the International Association of Pancreatology (Iap) ... [Et Al.] | |
| dc.identifier.essn | 1424-3911 |